
Methods: A validated in vitro bovine blood CVVH & CVVHD model using polysulfone (HF1400) & AN69 (Multiflow 150-M) hemofilters was performed to evaluate transmembrane clearances at different effluent flow rates. Adsorption experiments of C/T over 1 hour were determined in the study for each filter type. Each experiment was repeated 6 times with a new filter.
Results: The mean C/T sieving coefficient (SC) values from CVVH with three different ultrafiltration flow rates (16, 33, and 50 mL/min) ranged from 1.01-1.05 for ceftolozane and 1.27-1.31 for tazobactam from both hemofilters. For CVVHD with either filter, the mean saturation coefficients (SA) determined from four different dialysis flow rates (16, 33, 50 and 100 mL/min) of ceftolozane ranged from 0.70-1.04. Mean tazobactam SAs ranged from 1.09-1.32. Both SC and SA values were not different at any effluent rates. CVVH and CVVHD CLTM of C/T were shown in the Table. CVVH & CVVHD CLTM for both hemodiafilter types were not significantly different from each other. No C/T adsorption occurred for either hemodiafilter.
Conclusion: CRRT clearances of C/T depend on effluent flow rates but not hemofilter type. Adsorption of C/T did not influence CRRT clearance substantially. The C/T CRRT clearance with commonly prescribed CRRT rates (35-50 mL/min) are approximately 90%/25% (respectively) of reported non-renal C/T clearance values in anuric patients. Dosage adjustment is likely necessary for CRRT.
Table C/T CVVH and CVVHD Transmembrane Clearances
Effluent rates |
Mean(SD) Ceftolozane CLTM (mL/min) |
Mean(SD)Tazobactam CLTM (mL/min) |
||
HF 1400 |
AN 69 |
HF 1400 |
AN 69 |
|
CVVH |
||||
16 mL/min |
17.46 (1.27) |
16.97 (2.51) |
21.82 (1.53) |
21.10 (3.43) |
33 mL/min |
33.93 (5.86) |
34.55 (2.67) |
37.78 (10.94) |
42.85 (4.36) |
50 mL/min |
50.56 (4.39) |
51.06 (3.79) |
64.13 (7.16) |
64.83 (9.13) |
CVVHD |
||||
16 mL/min |
16.31 (3.48) |
17.28 (2.52) |
19.50 (2.71) |
20.01 (1.70) |
33 mL/min |
33.97 (8.69) |
30.14 (9.09) |
42.52 (6.64) |
36.25 (9.60) |
50 mL/min |
45.69 (12.28) |
51.39 (13.18) |
62.96 (12.98) |
66.07 (17.04) |
100 mL/min |
86.06 (12.65) |
70.23 (15.34) |
124.29 (16.36) |
110.33 (21.01) |

W. Chaijamorn,
None
S. J. Lewis, None
B. Mueller, None
See more of: Poster Abstract Session